A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial of JKN2403 in COPD

Clinical trial NCT07351734 · RECRUITING

Trial details

NCT number: NCT07351734
Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

COPD (Chronic Obstructive Pulmonary Disease)

Start date: 2025-11-06
Primary completion: 2026-09-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.